Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878653 · ClinicalTrials.gov registry record
Alcohol-Containing Products' Effect on Breathalyzer Results in Healthy Adults Without Acute Intoxication
A clinical trial, sponsored by CHRISTUS Health.
- Completed
- Registry status
- 51
- Enrollment target
NCT04878653: Completed study, sponsored by CHRISTUS Health.
NCT04878653 is a clinical trial that has completed, run by CHRISTUS Health. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04878653 has completed, sponsored by CHRISTUS Health.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This study is a prospective, controlled study in healthy volunteers all of whom are residents, medical students, faculty physicians, or emergency department nursing and ancillary staff.
Primary Outcome
1\. The BACtrack S80 Breathalyzer was used in this study to measure each individual's breath alcohol concentration (BrAC) to estimate one's blood alcohol concentration (BAC). It is measured as a percentage, i.e. a measurement of 0.040 represents 0.04%. The generally accepted legal standard for alcohol intoxication in the United States is 0.08%. The Outcome Measures include mean readings for each group looking at readings greater than 0%, greater than 0.04%, and greater than 0.08%.
Interventions
- DEVICE BACtrack S80 Breathalyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2020-10-22 |
What the finished NCT04878653 record still lists
NCT04878653 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BACtrack S80 Breathalyzer is the first listed.
NCT04878653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04878653 about?
NCT04878653 is a clinical study titled "Alcohol-Containing Products' Effect on Breathalyzer Results in Healthy Adults Without Acute Intoxication". This study is a prospective, controlled study in healthy volunteers all of whom are residents, medical students, faculty physicians, or emergency department nursing and ancillary staff.
What is the current status of trial NCT04878653?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2020-02-25. Estimated completion is 2020-10-22.
What interventions are being tested in trial NCT04878653?
The interventions under investigation include: BACtrack S80 Breathalyzer (DEVICE).
Who is sponsoring clinical trial NCT04878653?
This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI